| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2002-10-3065 |
| P698 | PubMed publication ID | 12468426 |
| P50 | author | Renato Maserati | Q114371658 |
| Daria Lucia Trabattoni | Q37839182 | ||
| Mario Clerici | Q37839199 | ||
| Pasquale Ferrante | Q40925221 | ||
| Luca Piacentini | Q43177730 | ||
| Adriano Boasso | Q55188047 | ||
| Marina Saresella | Q56816795 | ||
| Mara Biasin | Q57323745 | ||
| P2093 | author name string | Lieping Chen | |
| Haidong Dong | |||
| Gene M Shearer | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2514-2520 | |
| P577 | publication date | 2002-12-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression | |
| P478 | volume | 101 |
| Q37634635 | A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART. |
| Q24655393 | Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1 |
| Q34245386 | Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques. |
| Q37111511 | An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1 |
| Q45105481 | B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). |
| Q27317015 | B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections |
| Q45410931 | B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels |
| Q37574770 | B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals. |
| Q80890589 | B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression |
| Q43625479 | B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection |
| Q24652520 | Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection |
| Q36086676 | CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes |
| Q59353589 | CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion |
| Q36510689 | Chronic innate immune activation as a cause of HIV-1 immunopathogenesis |
| Q38826536 | Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy |
| Q28743206 | Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation |
| Q35762422 | Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity |
| Q37410069 | Cryopreservation decreases receptor PD-1 and ligand PD-L1 coinhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes |
| Q36302378 | Cytotoxic activity of dendritic cells as a possible mechanism of negative regulation of T lymphocytes in pulmonary tuberculosis. |
| Q48959703 | Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. |
| Q61767245 | Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy |
| Q54715235 | ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. |
| Q37032948 | Effects of lung cancer cell-associated B7-H1 on T-cell proliferation in vitro and in vivo |
| Q34683647 | Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10 |
| Q35399263 | HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells |
| Q47680181 | High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer |
| Q36858879 | How Ebola and Marburg viruses battle the immune system |
| Q27489722 | IL-10 Signaling Blockade Controls Murine West Nile Virus Infection |
| Q37271034 | IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells |
| Q42217541 | Identification and characterization of bovine programmed death-ligand 2. |
| Q47138765 | Immune Checkpoint Inhibitors in Melanoma and HIV Infection |
| Q28298214 | Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade |
| Q56891188 | Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection |
| Q40377124 | Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses |
| Q34093793 | Immune evasive mechanisms contributing to persistent Leishmania donovani infection |
| Q34984010 | Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients |
| Q35611780 | Immunology of B7-H1 and its roles in human diseases |
| Q36558794 | Immunoregulatory role of B7-H1 in chronicity of inflammatory responses |
| Q35364931 | Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade. |
| Q37026262 | Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression. |
| Q35681604 | Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation |
| Q37171804 | Inhibitory B7-family molecules in the tumour microenvironment |
| Q34575119 | Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy |
| Q41919772 | Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes |
| Q36696881 | Lentivirus-induced immune dysregulation |
| Q46911895 | Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy |
| Q35928399 | Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. |
| Q34311546 | Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!! |
| Q59375534 | Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels |
| Q34597324 | NFATc1 regulates PD-1 expression upon T cell activation. |
| Q40089883 | NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147. |
| Q37338892 | Neuroinflammation and brain functional disconnection in Alzheimer's disease. |
| Q41891579 | New therapy to revert dysfunctional antibody responses during HIV-1 infection. |
| Q90000752 | PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy |
| Q37469795 | PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention |
| Q29618956 | PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression |
| Q33910421 | PD-1, gender, and autoimmunity |
| Q34597843 | PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. |
| Q35814368 | PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing |
| Q24339361 | PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response |
| Q35821958 | PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection |
| Q37408390 | PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes |
| Q35175502 | Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction |
| Q37312736 | Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab). |
| Q45382246 | Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals |
| Q35940670 | Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy |
| Q39050794 | Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer |
| Q24564396 | Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection |
| Q43537412 | Putting T cells to sleep: a new paradigm for immune evasion by persistent viruses |
| Q35755634 | Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults |
| Q36227971 | Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade |
| Q34466498 | Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options |
| Q24634293 | Role of PD-1 in HIV pathogenesis and as target for therapy |
| Q34017771 | Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells |
| Q37139996 | T-cell exhaustion in HIV infection. |
| Q28067520 | The Dynamics of T and B Cells in Lymph Node during Chronic HIV Infection: TFH and HIV, Unhappy Dance Partners? |
| Q37940960 | The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion |
| Q51602760 | The Phenotypic and Functional Features of Human M2 Macrophages Generated Under Low Serum Conditions. |
| Q44991707 | The adaptation model of immunity |
| Q38181142 | Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. |
| Q35852050 | Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery. |
| Q42932292 | Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands |
| Q37055901 | Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T Cells Associated with Dysfunction of Cell-Mediated Immunity after Colorectal Cancer Operation |
| Q35578386 | Viral infection of human lung macrophages increases PDL1 expression via IFNβ. |
| Q33475710 | siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals |
Search more.